INHX Financial Facts
Basic and diluted net loss per share: -0.07License fees and milestones: 1.01M
See Full Income Statement
Total current liabilities: 5.75M
Other liabilities, net of current portion: 688.83K
See Full Balance Sheet
Inhibitex (INHX) Earnings
|
Expand Research on INHX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +111.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/11  |
 |
Q311 | -$0.07 | -$0.09 | +$0.02 | $1.26M | $650K | N/A |  | | Details |
| 8/8/11 |
|
Q211 | -$0.09 | -$0.09 | $0.00 | $287.5K | $300K | N/A | | | Details |
| 5/6/11 |
|
Q111 | -$0.12 | -$0.12 | $0.00 | $287.5M | $290K | N/A | | | Details |
| 3/11/11 |
|
Q410 | -$0.11 | -$0.09 | -$0.02 | $287K | $360K | N/A | | | Details |
| 11/9/10 |
Q310 | -$0.08 | -$0.09 | +$0.01 | N/A | N/A | N/A | | | Details |
